Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 1396 AL 1410

"To Bean or Not to Bean": Therein lie the hype and the hope. Advice to people with Parkinson in my clinic about Mucuna pruriens

Cilia R, Katzenschlager R.

J Parkinsons Dis. 2026 Jun;16(4):788-794. doi: 10.1177/1877718X261442075. Epub 2026 Apr 29.

Case Report: Sublingual Levodopa in Advanced Multiple System Atrophy

De Leon M, Lee M, Hindmarsh J.

J Pain Palliat Care Pharmacother. 2026 Jun;40(2):375-379. doi: 10.1080/15360288.2026.2653551. Epub 2026 Apr 30.

Exploring the fatigue phenomenon in individuals with Parkinson's disease: an Italian multicenter cross-sectional study

Sarasso E, Pelosin E, Ruotolo I, Maieron M, Ferrero A, Quarone F, Grassi A, Putzolu M, Gardoni A, Lagravinese G, Di Biasio F, Agosta F, Galeoto G, Fabbrini G, Avanzino L, Filippi M, Mezzarobba S.

Acta Neurol Belg. 2026 Aug;126(4):1323-1333. doi: 10.1007/s13760-026-03039-3. Epub 2026 May 1.

Investigating Disordered Eating Behaviours Among Individuals Living With Neurodegenerative Disease: A Scoping Review

Buttifant E, Allogmanny S, Probst Y.

J Hum Nutr Diet. 2026 Jun;39(3):e70250. doi: 10.1111/jhn.70250.

Effect of transcutaneous electrical nerve stimulation associated to exercise for pain in Parkinson's disease: a randomized crossover clinical trial

Garcez PA, DeJesus BM, Oliveira LR, Lima LV, DeSantana JM.

Pain Manag. 2026 Jul;16(7):737-746. doi: 10.1080/17581869.2026.2660894. Epub 2026 May 4.

Atypical Dual-Task Cost and Reduced Attentional Neural Modulation in Parkinson's Disease With Freezing of Gait

Hwang IS, Chen YA, Wu RM, Huang CY.

Neurorehabil Neural Repair. 2026 Aug;40(8):631-642. doi: 10.1177/15459683261448466. Epub 2026 May 8.

Placebo-controlled three-armed pilot trial of Escitalopram or Nortriptyline for depressive symptoms in Parkinson's disease (ADepT-PD)

Schrag A, Embleton-Thirsk A, Carroll C, Serfaty M, Duncan G, Molloy S, Whipps J, McLennan B, Lewis G.

J Neural Transm (Vienna). 2026 Jul;133(7):1679-1686. doi: 10.1007/s00702-026-03170-8. Epub 2026 May 8.

A novel synaptic compartmentalization failure framework for neurodegeneration

Panigrahi B.

J Alzheimers Dis. 2026 Jul;112(1):93-103. doi: 10.1177/13872877261449379. Epub 2026 May 9.

Rituximab beyond oncology: targeting B-cell-mediated immunomodulatory therapy in neurodegenerative and neuropsychiatric disorders

Saha T, Vats T, Mehan S.

Immunopharmacol Immunotoxicol. 2026 Aug;48(4):583-618. doi: 10.1080/08923973.2026.2671714. Epub 2026 Jun 1.

Decoding Parkinson's progression: A multi-modal SuStaIn ensemble approach validated on real-world PPMI data

Hani M, Mahmoudi S, Benjelloun M.

Neurobiol Dis. 2026 Jul;225:107435. doi: 10.1016/j.nbd.2026.107435. Epub 2026 May 11.

Molecular Dialogues in the Mitochondria-Microbiome Crosstalk: Metabolites, Signaling, and Immunity

Koynova-Tenchov R.

Compr Physiol. 2026 Jun;16(3):e70164. doi: 10.1002/cph4.70164.

ACKR1/Duffy-null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)

Murtough S, Stellakis O, Mills D, Bjourson B, Chaplin V, Chauhan D, Chipp B, Cotic M, de Villiers J, Dzahini O, Elmslie F, Evans K, Gandhi S, Hughes DA, Jin H, Panconesi D, Skowronska A, Sisodiya SM, Silva E, Stinton V, Stuart-Smith S, Tarrant S, Taylor D, Varney L, Walters JTR, Wood M, Woodley J, Dello Russo C, Pirmohamed M, Bramon E.

Br J Clin Pharmacol. 2026 Jul;92(7):1977-1990. doi: 10.1002/bcp.70576. Epub 2026 May 13.

The US Parkinson's disease community demands prevention

The Lancet Neurology.

Lancet Neurol. 2026 Jun;25(6):533. doi: 10.1016/S1474-4422(26)00173-0.

New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment

Menozzi E, Toffoli M, Deleidi M, Di Monte DA, Blandini F, Krainc D, Sidransky E, Schapira AHV.

Lancet Neurol. 2026 Jun;25(6):602-614. doi: 10.1016/S1474-4422(26)00090-6.

Cumulative traumatic brain injury as a predictor of Parkinson's disease with sex-related differences

Lázaro-Figueroa A, Garza-Flores S, Reyes-Pérez P, Morales De Arcia A, Esquivias J, Caballero-Sánchez U, Guerra-Galicia CM, Estrada-Bellmann I, Oropeza D, Matuk-Pérez Y, Morelos-Figaredo E, Gandarilla-Martínez NA, Portillo-Sánchez A, Salinas-Barboza K, López-Pintor A, Angulo-Arrieta A, Nolasco-López M, Zayas-Del Moral A, Rentería ME, Alcauter S, Hernandez-Ponce F, González-González M, Luna-Rangel FA, Medina-Rivera A, Martinez-Ramirez D, Ruiz-Contreras AE; Mexican Parkinson's Research Network (MEX-PD).

Parkinsonism Relat Disord. 2026 Jul;148:108334. doi: 10.1016/j.parkreldis.2026.108334. Epub 2026 May 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias